Movement Disorders

Papers
(The H4-Index of Movement Disorders is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
332
May Infographic236
Movement Disorders: Volume 40, Number 6, June 2025165
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease162
Movement Disorders: Volume 40, Number 2, February 2025120
Issue Information111
John Michael Walshe (April 24, 1920–October 14, 2022)111
In Memoriam Mahlon R. DeLong (1938–2024)110
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism109
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?108
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 1296
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia86
The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?85
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers80
Assessing Intronic Variable Number Tandem Repeat ( VNTR) Expansions of the HSF1 78
Risk Factors for the Diagnosis of Progressive Supranuclear Palsy in the UK Biobank77
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy75
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy68
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model68
Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals68
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease67
Substantia Nigra Elasticity Measurement Using Transcranial Shear Wave Elastography: A Potential Biomarker for Parkinson's Disease65
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in H65
Biallelic Variants in SLC27A3 Cause a Complex Form of Neurodegeneration with Brain Iron Accumulati65
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property63
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia63
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure61
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials59
Multimodal Imaging Investigation of the Dentato‐Thalamo‐Cortical Pathway in Friedreich's Ataxia59
A GJA1 Variant Triggers Earlier SPG4 Onset by Destabilizing Deubiquitinase 57
Indirect Striatal Projection Neurons Drive a D2 Receptor‐Dependent Pathway to Dyskinesia and Dystonia56
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation53
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease53
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism53
Patients with Allan‐Herndon‐Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment52
Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies52
Friedreich's Ataxia in Colombia: A Population‐Based Study of Incidence and Socioeconomic Determinants50
Clinical Outcome Assessments for Functional Performance in Spastic Paresis: Systematic Review, Critique, and Recommendations49
The Lows of High Reward: Choking Under Pressure48
Compound Heterozygous Structural Variants in Cases with Unsolved PRKN ‐Associated Parkinson's Dise48
In Vivo Investigation of Glucose Metabolism in Idiopathic and PRKN‐Related Parkinson's Disease48
Navigating Visual Challenges: How Parkinson's Disease Alters Cognitive Priorities in Visual Search47
Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”47
Brain–Computer Interface Improves Symptoms of Isolated Focal Laryngeal Dystonia: A Single‐Blind Study46
Cortical Functional Connectivity Changes in the Body‐First and Brain‐First Subtypes of Parkinson's Disease46
Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18F‐Fluorodopa‐Positron Emission Tomography46
Plant‐Based Dietary Patterns and Parkinson's Disease: A Prospective Analysis of the UK Biobank46
Re‐emergent Tremor in Parkinson's Disease: Evidence of Pathologic β and Prokinetic γ Activity46
0.11405396461487